AGENDA
ENHANCE YOUR EXPERIENCE WITH MEDCHALLENGE!
This event features MedChallenge, a new feature from Medscape that allows you to go head-to-head against your peers in a series of medical questions. Earn points, deepen your knowledge, and fight for the top spot on the leaderboard!
LEARNING OBJECTIVES
Upon completion of this session, learners will have
- Increased knowledge regarding
- The clinical trial data evaluating targeted therapies for patients with NSCLC
- Greater competence related to
- Utilizing diagnostic methodologies to identify molecular alterations in patients with NSCLC
- Personalizing therapy for patients with NSCLC and molecular alterations
- Mitigating treatment-related adverse events in patients receiving targeted therapy for NSCLC
- Greater confidence in their ability to
- Communicate treatment considerations with patients with NSCLC and molecular alterations
CO-CHAIR
LEARNING OBJECTIVES
Upon completion of this session, learners will have
- Increased knowledge regarding
- Clinical trial data evaluating immunotherapy as treatment for patients with NSCLC
- Greater competence related to
- Selecting the most appropriate immunotherapy-containing regimen for a patient with NSCLC
- Managing irAEs in patients receiving immunotherapy for NSCLC
- Greater confidence in their ability to
- Communicate treatment considerations with the interprofessional team
CO-CHAIR
LEARNING OBJECTIVES
Upon completion of this session, learners will have
- Increased knowledge regarding the
- Rationale for utilizing systemic treatment in patients with early-stage NSCLC
- Key data from clinical trials evaluating systemic treatment in patients with early-stage NSCLC
CO-CHAIR
LEARNING OBJECTIVES
Upon completion of this session, learners will have
- Increased knowledge regarding the
- Role of various team members in the management of patients with NSCLC
- Clinical trial data evaluating regimens used for the treatment of patients with SCLC
- Greater competence related to
- Tailoring therapy for patients with SCLC
- Identifying potential treatment-related AEs in patients receiving therapy for SCLC
- Greater confidence in their ability to
- Leverage the use of the interprofessional team in order to optimize outcomes in patients with SCLC
CO-CHAIR
LEARNING OBJECTIVES
Upon completion of this session, learners will have
- Increased knowledge regarding
- The characteristics that prompt suspicion of a mesothelioma diagnosis
- Greater competence related to
- Individualizing therapy for patients with mesothelioma
- Greater confidence in their ability to
- Effectively communicate aspects of care with patients with mesothelioma
CO-CHAIR
LEARNING OBJECTIVES
Upon completion of this session, learners will have
- Increased knowledge regarding
- Importance of early lung cancer detection and screening
- Clinical trial data evaluating screening and early detection methods
- Greater confidence in their ability to
- Incorporate strategies into clinical practice that may improve early detection of lung cancer
CO-CHAIR
LEARNING OBJECTIVES
Upon completion of this session, learners will have
- Increased knowledge regarding
- The clinical trial data evaluating targeted therapies for patients with NSCLC
- Greater competence related to
- Utilizing diagnostic methodologies to identify molecular alterations in patients with NSCLC
- Personalizing therapy for patients with NSCLC and molecular alterations
- Mitigating treatment-related AEs in patients receiving targeted therapy for NSCLC
- Greater confidence in their ability to
- Communicate treatment considerations with patients with NSCLC and molecular alterations
CO-CHAIR
cover
fixed